| Class 2 Device Recall Aesculap |  |
Date Initiated by Firm | January 31, 2025 |
Date Posted | March 11, 2025 |
Recall Status1 |
Open3, Classified |
Recall Number | Z-1311-2025 |
Recall Event ID |
96223 |
Product Classification |
Clamp - Product Code HXD
|
Product | Numerous models of nonsterile hemostatic forceps:
(1) REF FB458R, Glover ATR.CLAMP CVD 215MM;
(2) REF FB459R, Glover ATR.CLAMP CVD 245MM;
(3) REF FB461R, Glover ATR.CLAMP 195MM;
(4) REF FB462R, Glover ATR.CLAMP 210MM;
(5) REF FB469R, Leland-Jones Peripheral CLMPSTR 195MM;
(6) REF FB567R, Cooley Pediatric Clamp 30DG30/165MM;
(7) REF FB568R, Cooley Pediatric Clamp 60DG 30/160MM;
(8) REF FB569R, Cooley Pediatric Clamp 90DG30/150MM;
(9) REF FB729R, Cooley Pediatric Clamp 17MM 170MM;
(10) REF FB730R, Cooley Pediatric Clamp 20MM175MM;
(11) REF FB736R, Cooley Pediatric Clamp 74MM 185MM;
(12) REF FB737R, Cooley Pediatric Clamp 86MM 195MM; and
(13) REF FB738R, Cooley Pediatric Clamp 108MM 260MM. |
Code Information |
GTIN numbers:
(1) REF FB458R - 04038653156078;
(2) REF FB459R - 04038653156085;
(3) REF FB461R - 04038653156108;
(4) REF FB462R - 04038653156115;
(5) REF FB469R - 04038653156184;
(6) REF FB567R - 04038653156948;
(7) REF FB568R - 04038653156955;
(8) REF FB569R - 04038653156962;
(9) REF FB729R - 04038653157617;
(10) REF FB730R - 04038653157624;
(11) REF FB736R - 04038653157686;
(12) REF FB737R - 04038653157693; and
(13) REF FB738R - 04038653157709.
|
Recalling Firm/ Manufacturer |
Aesculap Inc 3773 Corporate Pkwy Center Valley PA 18034-8217
|
For Additional Information Contact | Allison Longenhagen 001-484-2408373 |
Manufacturer Reason for Recall | The forceps have been used in ways not covered by the design resulting in breakage of the clamps. |
FDA Determined Cause 2 | Use error |
Action | The recalling firm issued letters dated 1/29/2025 on 1/31/2025 via certified mail return-receipt. The letter explained the reason for the correction, identified the product impacted, provided the risk to health, and the actions required for the customer/user. The actions included: (1) Review the Urgent Medical Device Correction Notification in its entirety and ensure all users within the consignee organization are informed about the correction. Post the notification where the affected products are stored. If the consignee is a distributor, they are to forward the notification to their customers. The correction is to be extended to the end user/customer level; (2) Determine the current inventory of the affected items and comply with the following instructions: (a) Use the products identified for clamping of tissue and small vessels only; (b) Inspect the products for end-of-life indicators prior to use; (c) Visually inspect the products which should be clean and free of any signs of corrosion and cracks. Check the joint and jaw in the open position from both sides (if needed, use magnification; (d) Test the function of the device, including the jaw area, for deformation and loss of tension.
An Acknowledgment Form was enclosed for completion and return via FAX or email within 2 weeks of receipt, even if the total inventory in the consignee location is 0. |
Quantity in Commerce | 1,147 forceps |
Distribution | Distribution was made nationwide and to PR. There was also government/military distribution.
Foreign distribution was made to Canada, Bermuda, Bahamas, and Qatar. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes.
|
|
|
|